Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Capital Expenditures: 2022-2023

Historic Capital Expenditures for Therapeutics (LENZ) over the last 1 years, with Jun 2023 value amounting to $24,000.

  • Therapeutics' Capital Expenditures fell 98.27% to $24,000 in Q2 2023 from the same period last year, while for Jun 2023 it was $2.0 million, marking a year-over-year change of. This contributed to the annual value of $468,000 for FY2024, which is 1460.00% up from last year.
  • Latest data reveals that Therapeutics reported Capital Expenditures of $24,000 as of Q2 2023, which was up 300.00% from $6,000 recorded in Q1 2023.
  • Therapeutics' Capital Expenditures' 5-year high stood at $3.3 million during Q1 2022, with a 5-year trough of $6,000 in Q1 2023.
  • In the last 2 years, Therapeutics' Capital Expenditures had a median value of $968,000 in 2022 and averaged $1.1 million.
  • Data for Therapeutics' Capital Expenditures shows a maximum YoY crashed of 99.82% (in 2023) over the last 5 years.
  • Over the past 2 years, Therapeutics' Capital Expenditures (Quarterly) stood at $1.0 million in 2022, then crashed by 98.27% to $24,000 in 2023.
  • Its last three reported values are $24,000 in Q2 2023, $6,000 for Q1 2023, and $1.0 million during Q4 2022.